Tapeworm Infestation Clinical Presentation

  • Author: Lisandro Irizarry, MD, MPH, FAAEM; Chief Editor: Rick Kulkarni, MD   more...
 
Updated: May 2, 2011
 

History

Many cestode infestations are asymptomatic. The organisms may be discovered by patients during defecation with the fecal passage of proglottids. Tapeworms may migrate from the rectum (possibly causing itching) and may be seen on toilet paper or undergarments. However, once symptoms occur, they are usually vague GI complaints of abdominal pain, cramps, anorexia, nausea, diarrhea, weight loss, or malaise.

T solium infections are usually asymptomatic; however, infected patients may have generalized complaints include epigastric or periumbilical discomfort; nausea; hunger; and weight loss, anorexia, or increased appetite. The cysticerci that develop with T solium infestations can be found anywhere in the body, but they mainly occur in the central nervous system and skeletal muscles, causing local inflammatory responses and mass effects from the cystic growth. If neurocysticercosis develops, seizure is the most common form of presentation, occurring in up to 80% of patients with parenchymal brain cysts or calcifications.

With T saginata infection, usually, the patient becomes aware of infection when worm segments are passed in the stool. Some patients complain of epigastric pain, diarrhea, and weight loss. Similar to T solium infection, the presence of cysticerci in T saginata infection can result in symptoms of obstruction of the appendix, biliary duct, and pancreatic duct.

Diphyllobothrium infestations may result in intestinal discomfort, diarrhea, vomiting, weakness, and weight loss.

The cestode is not invasive, but it does absorb a large amount of vitamin B-12 and interferes with vitamin B-12 absorption from the ileum, producing a megaloblastic anemia that resembles pernicious anemia (clinically and hematologically). The tapeworm must thus be in a proximal portion of the intestine, and probably intrinsic factor secretion is defective in the host (allowing for diminished capacity to absorb vitamin B-12).

Patients may complain of neurologic symptoms resembling pernicious anemia (eg, paresthesias, difficulty with balance, dementia or confusional states).

Hymenolepis typically produces asymptomatic infections; however, in patients who may have a number of parasites present, the patient can have vague symptoms of anorexia, abdominal pain, and diarrhea (the developing cysticercoids destroy their housing villi, thus with a number of parasites, significant enteritis may develop). The number of worms is regulated by the hosts nutritional and immunity states.

D caninum infections are mostly asymptomatic with some symptoms of abdominal pain, diarrhea, anal pruritus, and urticaria.

Echinococcosis infections are potentially dangerous because they typically remain asymptomatic until the cysts cause a mass effect on an organ, which can occur 5-20 years after the initial infestation.

Cystic echinococcosis

The larvae develop into the fluid-filled hydatid cysts that are implanted after being carried in the bloodstream and expand slowly over several years.

The liver is the most common site, followed by the lungs (10-30%) (mostly the right lobe (60%) and the lower lobes (60%); however, almost any tissue may be involved. In children, the lungs may be the most common site of cyst formation. Up to 40% of patients with lung cyst will have liver cysts as well.

Most patients have single organ involvement (85-90%), and most will have a solitary cyst (>70%).

These cysts do not metastasize, but they may be disseminated by accidental spillage.

Pulmonary cystic rupture may result in clinically impressive and misleading symptoms of cough, chest pain, and hemoptysis.

Alveolar hydatid disease

A lesion in the liver does not appear as a cyst but is a firm, solid, cancerlike mass that is primarily in the liver. Approximately 60-80% of the cysts are located in the right lobe of the liver. Single or multiple foci may be present.

Hepatic echinococcosis can cause epigastric pain and dyspepsia (up to 35%) and can mimic cholelithiasis or jaundice (up to 45%) from compression in the bile duct. In one third of the cases, the disease is found incidentally during the checkup for nonspecific symptoms (fatigue, weight loss, hepatomegaly).

The disease spreads from the liver by direct extension, by lymphatic or hematologic metastasis, or by peritoneal seeding.

Compression of the bile duct can occur, resulting in biliary colic or jaundice.

Next

Physical

T solium infections

The cysticerci that develop with T solium infestations can cause mass effects from the cystic growth leaving the physical findings dependent on the location and the size of the growth.

Although most patients have normal neurologic examinations, the most common presentation of neurocysticercosis is the neurologic manifestations of seizures and focal neurologic deficits, along with possible hydrocephalus, meningitis, and dementia. Predictably, signs of increased intracranial pressure occur, as well as headaches, visual changes, vomiting, ataxia, and confusion.

Clinical manifestations of spinal neurocysticercosis are nonspecific and dependent on the size and the location of the cysts.

To homogenize the diagnosis of neurocysticercosis, revised diagnostic criteria were proposed as followed:[4]

Absolute criteria

  • Histologic demonstration of the parasite from biopsy
  • Direct visualization of subretinal parasite on funduscopic examination
  • Evidence of cystic lesions showing the scolex on CT scan or MRI

Major criteria

  • Lesions highly suggestive of neurocysticercosis on neuroimaging studies (cystic lesions without scolex, ring or nodular enhancing lesion and parenchymal round calcifications)
  • Positive enzyme-linked immunotransfer blot assay (EITB) for the detection of anticysticercal antibodies
  • Spontaneous resolution of small single enhancing lesions
  • Resolution of intracranial cystic lesions after therapy with albendazole or praziquante

Minor criteria

  • Lesions compatible with neurocysticercosis on neuroimaging studies (CT or MRI showing hydrocephalus, abnormal enhancement of the leptomeninges, and myelograms showing multiple filling defects)
  • Clinical manifestations suggestive of neurocysticercosis (seizures, focal neurological deficits, increased intracranial pressure, intellectual deterioration)
  • Positive CSF ELISA for detection of anticysticercal antibodies or antigen
  • Cysticercosis outside the CNS

Epidemiologic criteria

  • Individuals coming from or living in an area where cysticercosis is endemic
  • History of frequent travel to cysticercosis endemic areas
  • Evidence of a household contact with T solium infection

Diagnosis is definitive in patients with either (1) one absolute criterion or (2) a combination of two major criteria, one minor criterion, and one epidemiologic criterion. Diagnosis is probable in patients who meet these criteria (1) one major criterion plus two minor criteria; or (2) one major criterion plus one minor criterion and one epidemiologic criterion; or (3) three minor criteria plus one epidemiologic criterion.

  • Ocular cysticercosis can be seen on ophthalmologic examination of the eye. Parasites may be seen in the posterior chamber of the eye.
  • Cysticercosis of the muscle and subcutaneous tissues can be palpated or seen on plain radiographs. Almost all patients with symptomatic muscle cysticercosis are reportedly from Asia.

Diphyllobothrium infestations

Megaloblastic anemia that resembles pernicious anemia (hyperchromic, macrocytic, megaloblastic anemia with thrombocytopenia and mild leukopenia) may be present. Additionally, while true pernicious anemia is associated with gastric achlorhydria, tapeworm-induced anemia is not.

Only D latum is associated with macrocytic anemia.

Of patients who are infected with this tapeworm, 40% have decreased vitamin B-12 levels, but fewer than 2% of those develop anemia, which seems to occur mainly in Scandinavian countries.

Echinococcosis infections

Hepatic echinococcosis can cause signs of abdominal pain and a palpable mass in the right upper quadrant.

The physical examination may mimic cholelithiasis or jaundice from compression of the bile duct. Additionally, the patient may have chronic pancreatitis and signs and symptoms therein as related to the location and the size of the cystic infestation.

Rupture or leakage of the hydatid cyst produces fever, urticaria, and potentially fatal anaphylaxis.

Pulmonary cystic rupture may result in clinically impressive hemoptysis.

Sparganosis

Sparganosis commonly presents as subcutaneous edema and invades not only the subcutaneous tissue but also the muscles, eyes, urogenital system, abdominal viscera, and rarely the central nervous system.

Coenurosis

Coenurosis caused by T multiceps presents as a space-occupying cystic lesion of the central nervous system and subcutaneous tissues, leading to symptoms of mass effects and obstruction.

Previous
Next

Causes

See Pathophysiology.

Previous
 
 
Contributor Information and Disclosures
Author

Lisandro Irizarry, MD, MPH, FAAEM  Chair, Department of Emergency Medicine, Brooklyn Hospital Center; Assistant Professor, Department of Emergency Medicine, Weill Cornell School of Medicine

Lisandro Irizarry, MD, MPH, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Medical Toxicology, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Patricia Phan, MD, FACEP, FAAEM  Residency Program Director, Department of Emergency Medicine, Brooklyn Hospital Center

Patricia Phan, MD, FACEP, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Richard S Krause, MD  Senior Clinical Faculty/Clinical Assistant Professor, Department of Emergency Medicine, University of Buffalo State University of New York School of Medicine and Biomedical Sciences

Richard S Krause, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Eddy S Lang, MDCM, CCFP(EM), CSPQ  Associate Professor, Senior Researcher, Division of Emergency Medicine, Department of Family Medicine, University of Calgary Faculty of Medicine; Assistant Professor, Department of Family Medicine, McGill University Faculty of Medicine, Canada

Eddy S Lang, MDCM, CCFP(EM), CSPQ is a member of the following medical societies: American College of Emergency Physicians, Canadian Association of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Rick Kulkarni, MD  Attending Physician, Department of Emergency Medicine, Cambridge Health Alliance, Division of Emergency Medicine, Harvard Medical School

Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: WebMD Salary Employment

Additional Contributors

The authors and editors of eMedicine gratefully acknowledge the contributions of previous author, Raquel Mora, MD, to the development and writing of this article.

References
  1. Eom KS, Rim HJ. Morphologic descriptions of Taenia asiatica sp. n. Korean J Parasitol. March 1993;31:1-6. [Medline].

  2. Del Brutto OH. Neurocysticercosis. Semin Neurol. Sep 2005;25(3):243-51. [Medline].

  3. Del Brutto OH, Santibanez R, Noboa CA, Aguirre R, Diaz E, Alarcon TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology. Feb 1992;42(2):389-92. [Medline].

  4. Del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, Takayanagui OM, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology. Jul 24 2001;57(2):177-83. [Medline].

  5. Stefanic S, Shaikenov BS, Deplazes P, Dinkel A, Torgerson PR, Mathis A. Polymerase chain reaction for detection of patent infections of Echinococcus granulosus ("sheep strain") in naturally infected dogs. Parasitol Res. Mar 2004;92(4):347-51. [Medline].

  6. Craig P, Ito A. Intestinal cestodes. Curr Opin Infect Dis. Oct 2007;20(5):524-32. [Medline].

  7. Garcia HH, Del Brutto OH, Nash TE, White AC Jr, Tsang VC, Gilman RH. New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg. Jan 2005;72(1):3-9. [Medline].

  8. Garcia HH, Gonzalez AE, Gilman RH. Diagnosis, treatment and control of Taenia solium cysticercosis. Curr Opin Infect Dis. Oct 2003;16(5):411-9. [Medline].

  9. Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. Jan 15 2004;350(3):249-58. [Medline].

  10. [Best Evidence] Del Brutto OH, Roos KL, Coffey CS, García HH. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med. Jul 4 2006;145(1):43-51. [Medline].

  11. Sotelo J, Marin C. Hydrocephalus secondary to cysticercotic arachnoiditis. A long-term follow-up review of 92 cases. J Neurosurg. May 1987;66(5):686-9. [Medline].

  12. Husain M, Rastogi M, Jha DK, Husain N, Gupta RK. Endoscopic transaqueductal removal of fourth ventricular neurocysticercosis with an angiographic catheter. Neurosurgery. Apr 2007;60(4 Suppl 2):249-53; discussion 254. [Medline].

  13. Morar R, Feldman C. Pulmonary echinococcosis. Eur Respir J. Jun 2003;21(6):1069-77. [Medline].

  14. Chen W, Xusheng L. Laparoscopic surgical techniques in patients with hepatic hydatid cyst. Am J Surg. Aug 2007;194(2):243-7. [Medline].

  15. Ozturk G, Aydinli B, Yildirgan MI, Basoglu M, Atamanalp SS, Polat KY. Posttraumatic free intraperitoneal rupture of liver cystic echinococcosis: a case series and review of literature. Am J Surg. Sep 2007;194(3):313-6. [Medline].

  16. Barnett K, Emder P, Day AS, Selby WS. Tapeworm infestation: a cause of iron deficiency anemia shown by capsule endoscopy. Gastrointest Endosc. Sep 2007;66(3):625-7. [Medline].

  17. Bildik N, Cevik A, Altintas M, Ekinci H, Canberk M, Gulmen M. Efficacy of preoperative albendazole use according to months in hydatid cyst of the liver. J Clin Gastroenterol. Mar 2007;41(3):312-6. [Medline].

  18. Carpio A. Neurocysticercosis: an update. Lancet Infect Dis. Dec 2002;2(12):751-62. [Medline].

  19. Chrieki M. Echinococcosis--an emerging parasite in the immigrant population. Am Fam Physician. Sep 1 2002;66(5):817-20. [Medline].

  20. Christie JD, Garcia LS. Emerging parasitic infections. Clin Lab Med. Dec 2002;24(3):737-72.

  21. Cox FE. History of human parasitic diseases. Infect Dis Clin North Am. Jun 2004;18(2):171-88, table of contents. [Medline].

  22. Craig P. Echinococcus multilocularis. Curr Opin Infect Dis. Oct 2003;16(5):437-44. [Medline].

  23. Craig PS, McManus DP, Lightowlers MW, Chabalgoity JA, Garcia HH, Gavidia CM. Prevention and control of cystic echinococcosis. Lancet Infect Dis. Jun 2007;7(6):385-94. [Medline].

  24. Falagas ME, Bliziotis IA. Albendazole for the treatment of human echinococcosis: a review of comparative clinical trials. Am J Med Sci. Sep 2007;334(3):171-9. [Medline].

  25. Garcia HH, Del Brutto OH. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol. Oct 2005;4(10):653-61. [Medline].

  26. Garcia HH, Gonzalez AE, Gilman RH. Diagnosis, treatment and control of Taenia solium cysticercosis. Curr Opin Infect Dis. Oct 2003;16(5):411-9. [Medline].

  27. Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. Jan 15 2004;350(3):249-58. [Medline].

  28. Khuroo MS, Wani NA, Javid G, Khan BA, Yattoo GN, Shah AH, et al. Percutaneous drainage compared with surgery for hepatic hydatid cysts. N Engl J Med. Sep 25 1997;337(13):881-7. [Medline].

  29. Kolars JC, Fischer PR. Evaluation of diarrhea in the returned traveler. Prim Care. Dec 2002;29(4):931-45. [Medline].

  30. Kraft R. Cysticercosis: an emerging parasitic disease. Am Fam Physician. Jul 1 2007;76(1):91-6. [Medline].

  31. Loukas A, Hotez PJ. Chemotherapy of helminth infections. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's Pharmacology. 11th ed. McGraw-Hill; 2006:1121-1141.

  32. McAdam AJ, Sharpe AH. Infectious diseases. In: Kumar V, Abbas AK, Fausto N, eds. Kumar, Robbins, and Cotran: Pathologic Basis of Disease. 7th ed. Philadelphia: Saunders; 2005:838-8.

  33. Moon TD, Oberhelman RA. Antiparasitic therapy in children. Pediatr Clin North Am. Jun 2005;52(3):917-48, viii. [Medline].

  34. Nash TE, Singh G, White AC, Rajshekhar V, Loeb JA, Proaño JV. Treatment of neurocysticercosis: current status and future research needs. Neurology. Oct 10 2006;67(7):1120-7. [Medline].

  35. Ong S, Talan DA, Moran GJ, Mower W, Newdow M, Tsang VC. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis. Jun 2002;8(6):608-13. [Medline].

  36. Romig T. Epidemiology of echinococcosis. Langenbecks Arch Surg. Sep 2003;388(4):209-17. [Medline].

  37. Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: review of an important emerging infection. Neurology. Nov 9 2004;63(9):1559-64. [Medline].

  38. White AC, Weller PF. Cestodes. In: Kasper DL, Braunwald E, Fauci AS, eds. Harrison's Principles of Internal Medicine. 16th ed. McGraw-Hill; 2005:1272-7.

Previous
Next
 
Adult tapeworm of Dipylidium caninum. Image courtesy of the Centers for Disease Control and Prevention (CDC).
Ultrasonographic appearance of echinococcal cysts (Gharbi type I, World Health Organization [WHO] standardized classification CE1).
Diagram of the Echinococcus life cycle. Image courtesy of the Centers for Disease Control and Prevention.
Table. Cestodes and Their Hosts
CestodePrimary HostIntermediate Host
T soliumHumansPigs, humans, dogs, cats, sheep
T saginataHumansCattle
DiphyllobothriumHumansFish
HymenolepisHumansHymenolepis nana: None; Hymenolepis diminuta: Rodents
D caninumHumans, dogs, catsFleas on dogs/cats
EchinococcusDogsHumans, sheep, cattle, goats, horses, camel
SpirometraHumans
T multicepsHares, rabbits, squirrels, humans (rarely)
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.